南京市梅山地区非肥胖人群动脉硬化的发生率及相关因素

王阳春, 仝瑞祥, 何忠华, 等. 南京市梅山地区非肥胖人群动脉硬化的发生率及相关因素[J]. 临床心血管病杂志, 2023, 39(10): 793-797. doi: 10.13201/j.issn.1001-1439.2023.10.011
引用本文: 王阳春, 仝瑞祥, 何忠华, 等. 南京市梅山地区非肥胖人群动脉硬化的发生率及相关因素[J]. 临床心血管病杂志, 2023, 39(10): 793-797. doi: 10.13201/j.issn.1001-1439.2023.10.011
WANG Yangchun, TONG Ruixiang, HE Zhonghua, et al. Incidence of arteriosclerosis and associated factors in non-obese population in Meishan district in Nanjing[J]. J Clin Cardiol, 2023, 39(10): 793-797. doi: 10.13201/j.issn.1001-1439.2023.10.011
Citation: WANG Yangchun, TONG Ruixiang, HE Zhonghua, et al. Incidence of arteriosclerosis and associated factors in non-obese population in Meishan district in Nanjing[J]. J Clin Cardiol, 2023, 39(10): 793-797. doi: 10.13201/j.issn.1001-1439.2023.10.011

南京市梅山地区非肥胖人群动脉硬化的发生率及相关因素

  • 基金项目:
    南京市医学科技发展基金项目(No:YKK20184、YKK21216、YKK22264)
详细信息

Incidence of arteriosclerosis and associated factors in non-obese population in Meishan district in Nanjing

More Information
  • 目的 探讨南京市梅山地区非肥胖人群动脉硬化(arteriosclerosis,AS)的发生率及相关危险因素。方法 收集2017年8月—2021年7月南京梅山医院体检中心招募的非肥胖人群861例,年龄24~84岁,平均(51.4±9.49)岁,其中男554例,女307例;BMI(22.69±2.50) kg/m2。采用自编问卷收集人口学与临床特征资料;采用AS测定仪测量臂踝脉搏波传导速度(brachial ankle pulse wave velocity,baPWV),以baPWV>1 400 m/s定义为AS,将患者分为AS组(382例)和非AS组(479例);采用彩色多普勒血流探测仪测量踝肱指数。比较两组之间临床资料的差异,并采用二元多因素logistic回归分析非肥胖人群发生AS的相关因素。结果 非肥胖人群AS的发生率为44.37%(382/861),二元多因素logistic回归分析结果显示,年龄(OR=1.11,95%CI 1.09~1.14)、收缩压(OR=1.09,95%CI 1.07~1.10)、脂肪肝(OR=1.82,95%CI 1.15~2.88)是AS的危险因素,BMI(OR=0.86,95%CI 0.80~0.92)是AS的保护因素。结论 非肥胖人群AS的发生率较高,需要重点关注高龄、高收缩压、脂肪肝和低体重人群。
  • 加载中
  • 表 1  两组一般资料

    Table 1.  General data between two groups 例(%), X±S, M(P25, P75)

    项目 总体(861例) AS组(382例) 非AS组(479例) t/χ2/Z P
    性别 5.39 0.022
      男 554(64.2) 262(68.6) 292(61.0)
      女 307(35.8) 120(31.4) 187(39.0)
    年龄/岁 51.40±9.49 55.57±8.54 48.08±8.89 -2.51 <0.001
    BMI/(kg/m2) 22.69±2.50 22.97±2.45 22.47±2.52 -2.91 <0.001
    SBP/mmHg 119.61±14.90 127.12±14.89 113.61±11.90 -4.80 <0.001
    DBP/mmHg 75.72±9.98 80.52±9.95 71.89±8.19 -3.96 <0.001
    AST/(IU/L) 20.39±7.10 21.45±7.64 19.54±6.52 -3.97 <0.001
    ALT/(IU/L) 21.58±2.02 23.22±12.52 20.27±11.44 -3.60 <0.001
    FBG/(mmol/L) 5.42±0.77 5.59±0.96 5.29±0.54 -5.66 <0.001
    脂肪肝 221(25.7) 127(37.1) 94(19.2) 20.67 <0.001
    目前吸烟 183(21.3) 76(19.9) 107(22.3) 0.76 0.403
    LDL-C/(mmol/L) 3.30±0.82 3.38±0.85 3.23±0.79 -2.73 0.006
    血尿酸/(μmol/L) 458.88±117.96 473.70±114.43 447.06±119.52 -3.31 0.001
    TG/(mmol/L) 1.10±0.84 1.23±0.84 0.99±0.82 -4.27 <0.001
    TC/(mmol/L) 5.41±0.93 5.56±0.93 5.30±0.91 -4.13 <0.001
    γ-GT/(IU/L) 18(14,27) 21(16,30) 17(12,23) -6.77 <0.001
    eGFR/(mL/min/1.73m2) 70.37±11.94 67.23±10.86 72.88±12.17 7.09 <0.001
    ABI 1.19±0.09 1.21±0.11 1.18±0.07 -3.75 <0.001
    腰围/cm 86.99±5.50 87.12±5.45 86.86±5.52 -0.69 0.245
    下载: 导出CSV

    表 2  多因素logistic回归分析

    Table 2.  Multivariate logistic regression analysis

    变量 OR 95%CI P
    性别 1.17 0.74~1.86 0.492
    年龄 1.11 1.09~1.14 <0.001
    BMI 0.86 0.80~0.92 <0.001
    SBP 1.09 1.07~1.10 <0.001
    AST 1.01 0.99~1.03 0.486
    FBG 1.08 0.83~1.41 0.580
    血尿酸 1.00 0.99~1.00 0.687
    LDL-C 1.04 0.84~1.29 0.710
    脂肪肝 1.82 1.15~2.88 0.011
    eGFR 0.99 0.97~1.00 0.110
    ABI 4.58 0.68~30.66 0.117
    γ-GT 1.00 0.99~1.01 0.883
    TG 1.23 0.96~1.57 0.100
    下载: 导出CSV
  • [1]

    Murakami T. Atherosclerosis and arteriosclerosis[J]. Hypertens Res, 2023, 46(7): 1810-1811. doi: 10.1038/s41440-023-01284-0

    [2]

    Poznyak A, Grechko AV, Poggio P, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation[J]. Int J Mol Sci, 2020, 21(5): 110.

    [3]

    彭林玉, 陈丽丹, 廖静雯. 久坐行为模式与超重或肥胖成人动脉粥样硬化风险及心率变异性的相关性研究[C]. 第十二届全国体育科学大会, 中国山东日照, 2022.

    [4]

    Park K, Li Q, Lynes MD, et al. Endothelial cells induced progenitors into brown fat to reduce atherosclerosis[J]. Circ Res, 2022, 131(2): 168-183. doi: 10.1161/CIRCRESAHA.121.319582

    [5]

    Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease[J]. Hepatology, 2010, 51(5): 1593-1602. doi: 10.1002/hep.23567

    [6]

    Kwak MS, Kim KW, Seo H, et al. Non-obese fatty liver disease is associated with lacunar infarct[J]. Liver Int, 2018, 38(7): 1292-1299. doi: 10.1111/liv.13663

    [7]

    Herrington W, Lacey B, Sherliker P, et al. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease[J]. Circ Res, 2016, 118(4): 535-546. doi: 10.1161/CIRCRESAHA.115.307611

    [8]

    中国营养学会肥胖防控分会. 中国居民肥胖防治专家共识[J]. 中国预防医学杂志, 2022, 23(5): 321-339. doi: 10.16506/j.1009-6639.2022.05.001

    [9]

    中国医疗保健国际交流促进会. 同步四肢血压和臂踝脉搏波速度测量临床应用中国专家共识[J]. 中国循环杂志, 2020, 35(6): 521-528. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202006001.htm

    [10]

    Zheng M, Zhang X, Chen S, et al. Arterial stiffness preceding diabetes: a longitudinal study[J]. Circ Res, 2020, 127(12): 1491-1498. doi: 10.1161/CIRCRESAHA.120.317950

    [11]

    王明海, 于振海, 张曙光, 等. 踝肱指数在下肢动脉缺血性疾病中的临床应用[J]. 中国血管外科杂志(电子版), 2011, 3(1): 59-61. https://www.cnki.com.cn/Article/CJFDTOTAL-XGWK201101034.htm

    [12]

    Moreyra E Jr, Moreyra C, Tibaldi MA, et al. Concordance and prevalence of subclinical atherosclerosis in different vascular territories[J]. Vascular, 2020, 28(3): 285-294. doi: 10.1177/1708538119894178

    [13]

    Bergström G, Persson M, Adiels M, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population[J]. Circulation, 2021, 144(12): 916-929. doi: 10.1161/CIRCULATIONAHA.121.055340

    [14]

    Wang X, Li W, Song F, et al. Carotid atherosclerosis detected by ultrasonography: a national cross-sectional study[J]. J Am Heart Assoc, 2018, 7(8): 110.

    [15]

    Spannella F, Di Pentima C, Giulietti F, et al. Prevalence of subclinical carotid atherosclerosis and role of cardiovascular risk factors in older adults: atherosclerosis and aging are not synonyms[J]. High Blood Press Cardiovasc Prev, 2020, 27(3): 231-238. doi: 10.1007/s40292-020-00375-0

    [16]

    Pan Y, Jing J, Cai X, et al. Prevalence and vascular distribution of multiterritorial atherosclerosis among community-dwelling adults in southeast China[J]. JAMA Netw Open, 2022, 5(6): e2218307. doi: 10.1001/jamanetworkopen.2022.18307

    [17]

    Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease[J]. Circ Res, 2021, 128(12): 1818-1832. doi: 10.1161/CIRCRESAHA.121.318535

    [18]

    Wolf D, Ley K. Immunity and inflammation in atherosclerosis[J]. Circ Res, 2019, 124(2): 315-327. doi: 10.1161/CIRCRESAHA.118.313591

    [19]

    孙旭, 袁洪, 黄志军, 等. 300例高血压前期者脉搏波传导速度与颈动脉硬化改变及相关性[J]. 中国动脉硬化杂志, 2009, 17(10): 823-826. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ200910007.htm

    [20]

    陈贻珊, 李俊平, 孔振兴, 等. 动脉硬化对成年人心脏结构、功能及运动变化特征的影响[J]. 中国动脉硬化杂志, 2018, 26(11): 1140-1146. doi: 10.3969/j.issn.1007-3949.2018.11.012

    [21]

    Metcalf PA, Meyer ML, Tanaka H, et al. Longitudinal associations of blood pressure with aortic stiffness and pulsatility: the Atherosclerosis Risk in Communities Study[J]. J Hypertens, 2021, 39(5): 987-993. doi: 10.1097/HJH.0000000000002731

    [22]

    Simon TG, Roelstraete B, Hagström H, et al. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort[J]. Gut, 2022, 71(9): 1867-1875. doi: 10.1136/gutjnl-2021-325724

    [23]

    Wu M, Zha M, Lv Q, et al. Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study[J]. Eur J Neurol, 2022, 29(5): 1534-1537. doi: 10.1111/ene.15277

    [24]

    邓江, 韩致毅, 肖彩兰, 等. 非肥胖型脂肪肝患病率及影响因素分析[J]. 临床肝胆病杂志, 2021, 37(11): 2600-2604. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD202111027.htm

    [25]

    Lin L, Zhang J, Jiang L, et al. Transition of metabolic phenotypes and risk of subclinical atherosclerosis according to BMI: a prospective study[J]. Diabetologia, 2020, 63(7): 1312-1323.

    [26]

    王耀羚, 戚本玲, 白丽娟, 等. 基于肥胖与肌量划分的人体成分类型与动脉硬化的关系研究[J]. 临床心血管病杂志, 2020, 36(10): 906-913. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2020.10.007

    [27]

    Huang J, Chen Z, Yuan J, et al. Association Between Body Mass Index(BMI)and Brachial-Ankle Pulse Wave Velocity(baPWV)in Males with Hypertension: A Community-Based Cross-Section Study in North China[J]. Med Sci Monit, 2019, 25: 5241-5257.

    [28]

    章佳, 赵亚超, 王飞, 等. 超重和非超重人群颈动脉斑块特征的比较研究[J]. 临床心血管病杂志, 2022, 38(10): 828-833. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.10.014

    [29]

    Charakida M, Jones A, Falaschetti E, et al. Childhood obesity and vascular phenotypes: a population study[J]. J Am Coll Cardiol, 2012, 60(25): 2643-2650.

    [30]

    Bravo PE, Morse S, Borne DM, et al. Leptin and hypertension in obesity[J]. Vasc Health Risk Manag, 2006, 2(2): 163-169.

  • 加载中
计量
  • 文章访问数:  740
  • PDF下载数:  0
  • 施引文献:  0
出版历程
收稿日期:  2023-06-26
刊出日期:  2023-10-13

目录